Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
September 20th, 2016
We describe procedures for the preparation and delivery of membrane protein microcrystals in lipidic cubic phase for serial crystallography at X-ray free-electron lasers and synchrotron sources. These protocols can also be applied for incorporation and delivery of soluble protein microcrystals, leading to substantially reduced sample consumption compared to liquid injection.
Overview
This article details the preparation and delivery of membrane protein microcrystals in lipidic cubic phase for serial crystallography at X-ray free-electron lasers and synchrotron sources. The protocols described also apply to soluble protein microcrystals, significantly reducing sample consumption compared to traditional methods.
Key Study Components
Area of Science
- Structural Biology
- Crystallography
- Membrane Proteins
Background
- Membrane proteins are crucial for various biological functions.
- Understanding their structure is essential for insights into their mechanisms.
- Traditional methods often lead to high sample consumption and radiation damage.
- Lipidic cubic phase provides a native environment for these proteins during crystallization.
Purpose of Study
- To develop protocols for preparing membrane protein crystals in lipidic cubic phase.
- To facilitate structure determination at room temperature with minimal sample loss.
- To enhance the understanding of membrane protein functions.
Methods Used
- Reconstitution of membrane proteins in lipidic cubic phase using specialized syringes.
- Injection of LCP samples into syringes for crystallization.
- Monitoring crystal growth under a stereo microscope.
- Consolidation of LCP samples for data collection.
Main Results
- Successful formation of membrane protein microcrystals in lipidic cubic phase.
- Reduced sample consumption and minimal radiation damage observed.
- Crystals identified as shiny particles or uniform glows under polarized light.
- Protocols established for effective sample handling and crystallization.
Conclusions
- The described methods enable effective crystallization of membrane proteins.
- These protocols can be adapted for various protein types.
- Future studies can leverage these techniques for advanced structural analysis.
Frequently Asked Questions
Executive Industry Relevance
Membrane proteins represent a major class of drug targets, yet their structural characterization remains challenging due to difficulties in crystallization and radiation sensitivity. The lipidic cubic phase-serial femtosecond crystallography (LCP-SFX) method enables room-temperature structure determination of membrane protein microcrystals with minimal radiation damage and reduced sample consumption. This approach supports early-stage target validation by providing high-resolution structural data from native-like lipid environments, informing rational drug design for GPCRs and other membrane-associated targets.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables structural interrogation of membrane protein targets in a near-native lipidic environment, supporting target hypothesis validation.
- Operational Value: Reduces sample consumption by utilizing microcrystals, allowing precious or difficult-to-express targets to be studied efficiently.
- Predictive Value: Provides high-resolution structural insights that aid in mechanistic de-risking and lead optimization efforts.
Screening & Assay Development
- Scientific Value: Produces well-diffracting microcrystals suitable for serial data collection, enabling reliable structural readouts for fragment or ligand screening.
- Operational Value: Standardizes sample delivery via LCP injectors, improving reproducibility and throughput in crystallographic workflows.
- Strategic Value: Supports platform reuse across multiple membrane protein targets, enhancing resource efficiency in structural genomics initiatives.
Translational & Preclinical Research
- Scientific Value: Delivers atomic-level details of ligand-binding sites, such as serotonin or smoothened receptor complexes, to support structure-based drug design.
- Operational Value: Facilitates room-temperature data collection, reducing cryo-artifacts and improving physiological relevance of structural data.
- Translational Continuity: Connects early discovery structural data to preclinical optimization by enabling iterative design-make-test-analyze cycles.
Pipeline & Workflow Integration
The LCP-SFX method integrates into the discovery workflow following target expression and purification, providing structural inputs for hit-to-lead and lead optimization stages. It enables iterative structural feedback during preclinical development by allowing rapid re-solving of protein-ligand complexes.
- Discovery Biology: Supports target validation by resolving membrane protein structures in lipidic environments that mimic native membranes.
- Screening: Enables structural assessment of ligand binding modes when microcrystals are soaked or co-crystallized with compounds.
- Analytics: Generates electron density maps and refined models that quantify ligand interactions and conformational states.
- Translational Research: Provides structural templates for optimizing drug candidates against membrane protein targets in preclinical models.
- Enterprise Reuse: Establishes a standardized platform for membrane protein structural characterization across multiple projects and targets.
Operational & Enterprise Impact
- Scientific Value: High-resolution structures from native-like environments increase confidence in target mechanism and ligand interactions.
- Operational Value: Minimizes sample usage and radiation damage, enabling data collection from challenging or low-yield targets.
- Strategic Value: Accelerates lead optimization by reducing structural uncertainty in drug-target interactions.
- Portfolio Impact: Informs go/no-go decisions through improved understanding of target druggability and binding site plasticity.
Implementation Considerations
- Expertise in membrane protein biochemistry and lipidic cubic phase handling is required.
- Access to X-ray free-electron laser or advanced synchrotron beamlines is necessary for data collection.
- Standardized protocols for LCP preparation, crystal detection, and sample loading ensure reproducibility across teams.
- Adaptation to different membrane protein systems may require optimization of lipid composition and precipitant conditions.
- Practical limitations include the need for specialized injection equipment and expertise in serial crystallography data processing.
Biopharma FAQs
Chapters in this video
0:05
Title
0:54
Setting up Crystallization in Syringes and Crystal Detection
4:06
Sample Consolidation and Titration with 7.9 Monoacylglycerol (MAG)
6:32
Characterization of Microcrystals
7:44
Results: Representative Results of Sample Preparation Procedure and Final Protein Structures
8:27
Conclusion
